Ahnormal .;c.cr-ctions have 1,cc.n I-ccogni/ctl lbr-some time :IS orlc ol' the h;isic al,nor-rn;rlitics i l l ~~:rticnts with ('I' ( 1 , 2). li)rcxaml,lc the elevation ol'\otlium Icvcls in seer-ctioris is a consistent Iintlir~g iri ('1. (3).
Ahnormal .;c.cr-ctions have 1,cc.n I-ccogni/ctl lbr-some time :IS orlc ol' the h;isic al,nor-rn;rlitics i l l ~~:rticnts with ('I' ( 1 , 2). li)rcxaml,lc the elevation ol'\otlium Icvcls in seer-ctioris is a consistent Iintlir~g iri ('1. (3) .
Salivi~r-y glarrds seer-ctc a n isotonic solution ol'clcct~-olytcs and m:icr-omolcc.rrlc.;, but during its Ixrssagc tlrrougli the glantlul:rr ducts ions arc rcahsor-llctl and thc solution I~ccorlics Iiypo(onic. 1):rnn and Iflatr (4) suggested in 107X that the rcahsor-plion 01' ions in glantluli~r ducts is contr-ollctl by :(I-gininc cstci-ascs which arc ~,r.cscrrl in the 1:l;rntls. At the w m c lime thcy ~,r-ol,osctl th:rt abnormal clcctr-olvtc conccrltr-ations in ('1: sccr-ctions arc c:r~rscd by a tlclicicncy ill cithc*r-tlic glandular-hallikrcin, whicll itsc~lI'li:rs 21-gi nine ester-asc activity, or-in sorric otlicr-ar-gininc cstcrasc. In 108 I I lallinan ( 5 ) c*xl,;rntlctl this hypotlicsis and 111-oposcd that ('I.' coultl Ilc tluc to a possible dcl'cct in a n intr-acclli~lar-cn/ynic. which earl-iCs out :in ;IS yet ~rnhnown l,ut Iirnction:rlly impor-t:rnt posttranslational modification to the arginine esterases, for example a glycosylation or phosphorylation. Catanzaro et ul. (6) demonstrated in 1978 that kallikrein is involved in the control of Na' , Kf, and H20 secretions in the saliva of the rat. Subsequently it has been shown that kinins, which are small peptides that are produced by kallikrein through cleavage of kininogens, are directly involved in the inhibition of electrolyte absorption in guinea-pig ileum (7) . Because of these findings it was decided to study the kallikreins in normal and CF saliva and to investigate whether the hypothesis of Dann and Blau (4) or that of Hallinan ( 5 ) is correct.
The isolation of human salivary kallikrein has been reported by Fujimoto et ul. (8) and by Modeer (9) . More recently Hoffman et a/. (10) isolated this enzyme by selective catheterization of glandular ducts while Wong et ul. (1 1) purified the enzyme from parotid saliva. However, significant differences have been reported in the properties of the purified salivary kallikreins, for example in isoelectric focusing and molecular weights. We have therefore recently developed a new method to purify kallikrein from human whole saliva. Several properties of the purified kallikrein from the saliva of CF patients will now be reported . . .... togctilcr w~tii tilose oi tile nor-rnal kallrlircin tiiat i1:rvc n o t ixcn Wliolc saliva, stiili~rl;itctl hy clicwing tlcnt:il wax (('yhrorr/ Kcr-I-) was ohlarrictl 11-om holh male ;~ntl Ibmalc volunteers. I hc ('1: ~xrticnts wcrc in tlic age gr-oup hctwccn I X and 25 yr. 'l'hcy wcr-c all di;ignoscd at :I young age witli the sweat-test and they 1i:rvc hccn ~rndcr-I-cgul:rr. ohscr.v:rtion in tlic ('1:-clinic at tlic I.W.K. I 1ospit:rl li)r ('hildr-cn in I lalilirx, N.S. <':rnad:i, which is under tlic dir-cction o f I>r. ('. I ' . <;illcspic. 'l'lrc patients wcr-c mostly univcr~sity students and wcrc corlsitlcrcd to hc in good contlitiorr. 'l'hcy 131-otluccd each :ibout 1 S O ml saliva per tur-n and the s;iliva ol'thr-cc to li)ur palicnts wcrc poolctl lo give a volumc 01' aho~rt 5 0 0 ml. I'lic ~,oolcd s:rmplcs consistently contained higher-conccntr-;rtions 01' protein, car-boliydratc, and n o n d i~l y~a -blc compo~rntls, tlran normal s:rliv:r.
A Sl,hcr-ogcl-'I'SK 3000SW column (7.5 X 300 mm) was pur-chasctl l'roni I3cckman Instruments liw use irr I 11' 1 .<'.
'l'lic synthetic suhstratc I1AI:1: anti 11-ypsin inhihitor-s wcr-c obtainctl I'rom Sigma.
'l'hc I,LII-ilication 171-occd~ir-c li)r-salivar-y kalli kr-cin is tlcscr-ihcd clscwhcrc ( I?). I'hc same proccd~rr.c was ~rscd li)r normal and (2.' s:lliv:l.
1'1-otcin dctcr-minitlions wcrc donc with ('oomassic I3luc by the I3io-liatl rnctliod (1 3) and a protein st:rndartl, purcli~rscd li.om I3io-li:rd, was included in c:rch tlctcr-min:rtiori. I:nLymatic irctivity was tlclcr~ninctl wilh I3Al:li as subslralc :rnd lhc rcaclion was monitored :it 353 nm ( 14) witli a ( ' :rr-y 14 I-ccording spcctr-opholomctcr-.
(;el clcctrophorcsis h:rs Ixcn donc :is dcscribccl clscwlicrc ( 12) ant1 tlrc inolccul;rr wciglits ol'thc s:rliv:rr-y kallikr-cins wcr-c calcu-lated from their mobilities in the SDS containing gels using a reference mixture of standard proteins (obtained from Pharmacia). lsoelectric focusing was done using a LKB 8101 column (LKB, Sweden). The pH gradients were formed with Pharmalyte pH 2.5-5.0 in sucrose density gradients.
Amino acid analyses were done with a Beckman model 6300 analyser after hydrolysis of the enzymes in 6 M HCI. Separate samples were oxidized with performic acid at 2" C for 4 h and then analyzed for cysteic acid and methionine sulfone (15) . Tryptophan was determined by the method of Goodwin and Morton (16) .
Fluorescence measurements were made with an Aminco-Bowman spectrofluorometer at room temperature, using a 3 mm2 cuvette which requires only 100 of solution. The spectra were corrected as outlined by Melhuish (1 7) and a horizontally oriented polarizer was used in the excitation beam to reduce scattering (18) . The corrected intrinsic fluorescence spectra were analyzed to determine the number of independent fluorescent components (19) .
Circular dichroism spectra were measured at wavelengths below 240 nm with a Cary 6001 instrument. The data were converted to deg . cm2. dmol-' (20) using a mean residue weight of 107 as calculated from the amino acid composition. The secondary structures were computed using the method of Chang PI 01. (20) , who also provided us with the four reference spectra, cJ.g. those for a-helix, pleated sheet, P-turns, and unordered structures. The following constraints were used: ( I ) none of the aforementioned structures could be present in the protein at more than 100% or less than 076, and (2) the sum of the four structures must be 100%.
RESULTS
The flow chart illustrated in Figure 1 summarizes the procedure for the purification of a salivary BAEE-esterase from either CF patients or normal individuals. It has previously been shown that a partially purified BAEE esterase from normal saliva produces kinins in acid-treated dog plasma (2 1). The same enzyme also reduces the blood pressure of a rabbit when injected intravenously. This enzyme therefore seems to belong to the glandular kallikreins.
Afinity chromatography on BPTI-Sepharose gives the greatest increase in purity in a single step, but it fails to remove an inactive protein component from the enzyme. Complete purity of the enzyme is not obtained until after HPLC on a Spherogel-TSK 3000 SW column (see Fig. 2 ). HPLC separates two protein components, but only the material that elutes between 21 and 24 min contains enzymatic activity, the other component i:s completely inactive. The inactive component is present in normal and in C F saliva and appears to bind to the kallikreiri because it does not itself show affinity for the BPTI-Sepharose column.
The saliva of C F patients contains similar BAEE esterase activity as saliva of normal controls. Examples of the purification of kallikrein from saliva are shown in Table 1 . Understandably the data fluctuate between different batches of saliva but the results shown in Table 1 are quite typical. It can be seen that the final purification of the CF kallikrein and its activity are the same as that for the normal enzyme, and this purification as well as the yield does not vary more than 10-20% from batch to batch. Polyacrylamide gel electrophoresis experiments at pH 9.5 and at pH 8.2 in the presence of SDS, show that the CF enzyme has normal mobilities (see Fig. 3 ). The molecular weights have been determined from the mobilities in the SDS containing gel and a value of 40,000 has been calculated for both normal and CF salivary kallikrein.
The amino acid compositions of the enzymes are shown in Table 2 . The compositions are very similar. Both enzymes contain a large number of aspartic and glutamic acid residues and only small numbers of the various basic residues. The p1 values of the salivary kallikreins have also been determined by isoelectric focusing and as anticipated from the amino acid compositions, low values, p1 = 4.00 5 0.08, have been found. The methionine and cysteine contents of both enzymes are very low and an accurate determination of these residues proved to be almost impossible. Slight discrepancies have been observed for the proline and valine residues but otherwise the amino acid contents are the same within 1 SD (n = 4).
Normal and CF salivary kallikrein each contain 1 mol percent of tryptophan whose presence has also been demonstrated by measuring the intrinsic fluorescence spectra. The corrected excitation spectra of both enzymes at pH 7.0 show a maximum at 282 nm while the corrected emission spectra show a broad peak centered at 338 + 1 nm (see Fig. 4 ). The fluorescence intensities at 338 nm are the same for normal and CF enzyme solutions after correcting for the difference in absorbances at 275 nm. An algebraic method was used to analyze the emission spectra obtained at four different wavelengths of excitation, and it was 0 1 0 20 3 0 40 TIME (min) Fig. 2 . HPLC of normal and CF kallikrein on a Spherogel-TSK 3000 SW column (7.5 x 300 mm). The flow rate was 0.6 ml of 0.01 M phosphate pH 5.6 per min at room temperature. found that two independent groups contribute to the intrinsic fluorescence of normal and CF kallikrein. These groups are presumed to be tyrosine and tryptophan.
The CD spectra of the salivary kallikreins are shown in Figure  5 . Both spectra show a maximum negative ellipticity at 197 f 1 nm with values of [O] =-12,000 k 1,300 deg.cm2.dmol-I. The curves were analyzed with a computer using four basic reference spectra, and the results are shown in Table 3 . It can be seen from Table 3 that the salivary kallikreins have no a-helix structure.
On the other hand, the enzymes have substantial amounts of pleated sheet structure. The data of Table 3 have been used to calculate the best fit of the observed spectrum for normal kallikrein (see Fig. 5 ). This computed curve resembles, but does not exactly fit, the observed spectrum.
The enzymatic properties of the CF salivary kallikrein have been investigated and compared with those of the enzyme obtained from control saliva. Neither enzyme cleaves azocasein nor are they inhibited by soybean or lima bean trypsin inhibitors. On the other hand, both enzymes are inhibited by BPTI and also by di-isopropyl fluorophosphate. As shown in Table 4 the enzymes also reduce the blood pressure of a rabbit when injected intravenously. When 10 micrograms protein, corresponding to 20-25 ml saliva, is injected the rabbit's blood pressure is reduced by about 10 mm Hg.
The pH rate profiles for normal and CF salivary kallikreins are shown in Figure 6 . It can be seen that neither enzyme cleaves BAEE at pH values below 5.0. The activities increase rapidly above pH 6.0 and reach maximum values at pH 8.2 f 0.2. At high pH the enzymes remain fairly active and at pH = 10.0, for example, the activities are still about 80% of the observed maxima.
When the concentration of the substrate BAEE is increased to in excess of 1 mM, the reaction velocities begin to decrease. This substrate inhibition is observed for both CF and normal salivary kallikrein, and with freshly recrystallized BAEE. Figure 7 illustrates the double reciprocal plots of velocity versus BAEE concentration for the enzymes. These Lineweaver-Burk plots are linear if the data points at higher BAEE concentrations are ignored. By extrapolating these linear parts of the plots one obtains the apparent values for Km and Vmax which are shown in Table 4 . From this Table 4 it is evident that the CF and normal salivary kallikreins have very similar kinetic parameters.
DISCUSSION
A BAEE-esterase has been purified from whole saliva from CF patients and controls. The demonstrated activities and biological effect of this enzyme and also the effects of trypsin inhibitors on the esterase activity, made us name this enzyme a kallikrein.
The batches of CF saliva showed often a higher viscosity than the normal batches but this did not appear to affect the purification procedure. The yield and the purification factor indicate that CF saliva contains a normal level of kallikrein which amounts to 0.4-0.5 pg/ml. The most important purification step is the affinity chromatography on a BPTI-Sepharose column. However, not all the inactive protein components are removed during this step, because an inactive protein, which is rather proline-rich, is still present. HPLC has shown that this is the case for normal as well as CF saliva. Since this inactive contaminant does not bind to the BPTI-Sepharose column it is assumed to be associated with the salivary kallikreins, from which it dissociates at weekly acidic pH. The enzymes purified from CF and normal saliva show identical electrophoretic mobilities in polyacrylamide gels at pH 9.5 and in gels containing SDS at pH 8.2. Both enzymes show only one band in either gel which proves that they are pure. The identical mobilities of the enzymes in the presence of SDS suggests that the CF kallikrein has the same molecular weight of 40,000 as the normal enzyme. The latter's molecular weight has previously been confirmed by sedimentation equilibrium (1 2).
The amino acid compositions of CF and normal kallikreins are very similar. Both enzymes have high contents of acid residues while the basic amino acid residues are only small in found for an acyl-enzyme intermediate. The initial hydrolysis of the artificial substrate BAEE is linear with time. The pH rate profiles are not exactly bell-shaped as they only show a minor drop in activity at high pH values. Substrate inhibition is observed with BAEE at pH 8.2 even if carefully purified substrate is used. The inhibitions at high BAEE concentrations are identical for the normal and C F enzyme. Since we have observed that polylysine also lowers the enzymatic activity it is believed that the substrate inhibition is caused by interactions on secondary binding sites. The presence of such sites could explain the fact that the pH rate profiles are not bell-shaped, because a decrease in BAEE affinity at these sites would obscure the reduction in arginine esterase activity at high pH. Regardless of the mechanism of the substrate inhibition its effect seems to be small at low concentrations of BAEE. Thus linear LineweaverBurk plots are still observed at low substrate concentrations. The kinetic parameters calculated from these plots for normal and C F kallikreins are almost identical, despite the fact that long extrapolations are required which means that the results could be somewhat less reliable.
Thus our study shows that salivary kallikrein is present at the same level in C F saliva as in normal saliva and that it has very similar physicochemical properties. CD measurements attest to identical secondary structures while the intrinsic fluorescence indicates similar conformations. Furthermore the enzymatic properties of the CF salivary kallikrein are the same as those of the normal enzyme. It is therefore concluded that the salivary kallikrein in C F is not defect and that its activity is quite normal.
